Purchase Order 75N93019P00134
Award Date
12/4/18
Potential Completion Date
2/28/19
Potential Value
$4.8K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Wuxi Apptec (Hongkong) LIMITED
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hong Kong International Airport, 1 Sky Plaza Rd, Chek Lap Kok, Hong Kong
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Wuxi Apptec (Hongkong) LIMITED, a global provider of research and development services to the pharmaceutical and healthcare industry. The $17,750.00 firm fixed price purchase order is for the synthesis of six analogues of OSMI-4A, with a period of performance from August 28, 2020 to November 6, 2020. The...
This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract provides for the synthesis and delivery of 0.2 grams of the small molecule Marizomib, with a purity of 95% or above, as well as a report detailing the synthesis and purity information. The contract has a ceiling value of $10,800.00 and a performance period of approximately 20 weeks from...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract, valued at $128,000.00, is for the synthesis of 2R,6R-hydroxynorketamine hydrochloride. The contract is a firm fixed price purchase order with a completion date of January 21, 2017. The contract does not have a set-aside designation. Wuxi Apptec (Hongkong) LIMITED is a global contract research and development...
This is a federal purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $12,800.00 firm fixed-price contract was awarded to Wuxi Apptec (Hongkong) Limited, a for-profit limited liability company, to obtain 5 small molecule compound libraries. The contract has no set-aside designation and the ultimate completion date is October 9, 2021. Wuxi Apptec is a global...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Purchase Order contract to Asischem Inc. to provide custom synthesis of a chemical compound. The contract, valued at $4,890.00, was awarded on August 3, 2015 with a completion date of December 1, 2015. This contract was not set aside for any specific business type or size. Based on the agency name, this contract is likely related to NIAID's research and development programs focused on infectious...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $28,000 firm fixed price purchase order to Karebay Biochem Inc. under request for quotes RFQ-NIAID-23-2175814. The contract calls for the delivery of a peptide library consisting of 408 peptides, each with 1 milligram of a 15 amino acid peptide at 95% purity. The place of performance is China. The award was set aside for total small business and will...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to 10X Genomics, Inc. for the delivery of various 10X Chromium reagents and equipment. The total ceiling value of the contract is $88,170.63, with an ultimate completion date of December 31, 2024. The contract provides specialized kits, instruments, and services to support single-cell RNA sequencing research...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients, to provide 1 gram of RON2 acetate salt peptide. The contract has a potential value of $45,750.00 and a completion date of January 18, 2019. The procurement was a sole-source award based on Bachem's status...
This is a $24,992.79 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to 10X Genomics, Inc., a for-profit manufacturer of genomic analysis products. The contract is for the delivery of 10X Expression Kits, which support single-cell RNA sequencing, single-cell ATAC sequencing, multi-omics analysis, and spatial transcriptomics research. This contract is not set aside and...